ARIMA GENOMICS, INC.
Single-cell multiomic analysis platform integrating chromatin interactions (Hi-C), accessibility (ATAC), gene expression (RNA), and protein detection in one scalable workflow
- Sector
- Biotech
- Headquarters
- San Diego, CA
- Total capital
- $21M
- Federal grants
- $20.5M
- 23 awards · 2015–2024
- Rank in peer group#2 of 42
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $457K
- 21 awards · Agriculture, Health and Human S, Veterans Affairs
- Rank in Biotech#234 of 4373
- Granted patents
- 4
- 36 pending · first 2022
- Rank in peer group#10 of 42
Capital timeline
Latest events
- Federal contractHealth and Human S · Biological And Reagent Material - Arima Hic+ For Hic (8 Reaction)$12K
- Federal contractHealth and Human S · Arima Genomics Hic Sequencing And Qc Service$60K
- Federal contractHealth and Human S · Arima Genomics INC:1284747 [24-044276]$12K
- Federal contractHealth and Human S · Arima Genomics INC:1284747 [24-004616] Reagents$30K
- Federal grantHealth and Human S · Phase II · Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors$1.9M
- Federal grantHealth and Human S · Phase II · Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity$1.1M
- Federal contractVeterans Affairs · Low-input Genome-wide Hic Mouse Gene Sequencing$27K
Show 36 earlier federal awards
- Federal contractHealth and Human S · Arima Genomics INC:1284747 [23-004496]$35K
- Federal grantHealth and Human S · Phase II · Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors$2.1M
- Federal grantHealth and Human S · Phase II · Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity$1M
- Federal grantHealth and Human S · Phase II · A scalable kit-based assay for multi-omic analyses of transcriptional protein binding and chromatin interactions from ultra-low input frozen and FFPE samples at single-cell resolution$1M
- Federal contractHealth and Human S · Laboratory Supplies - Reagent Kits.$13K
- Federal contractHealth and Human S · Arimagenomics, Hic And Hichip$47K
- Federal contractHealth and Human S · Arima Hic Custom Tier 2 Kit$15K
- Federal contractHealth and Human S · Arima Genomics INC:1284747 [22-015447] Laboratory Supplies$22K
- Federal grantHealth and Human S · Phase II · A low-input compatible, end-to-end kitted HiChIP workflow for concurrent analyses of transcriptional protein binding and chromatin interactions toward a mechanistic understanding of gene regulation$983K
- Federal grantHealth and Human S · Phase II · A scalable kit-based assay for multi-omic analyses of transcriptional protein binding and chromatin interactions from ultra-low input frozen and FFPE samples at single-cell resolution$2.1M
- Federal contractHealth and Human S · Arima Genomics INC:1284747 [21-042365] Kit For Hichip$22K
- Federal contractHealth and Human S · Purchase Of Kits For Research Project.$15K
- Federal contractAgriculture · Proximity Ligation Library Construction And Sequencing$4K
- Federal grantHealth and Human S · Phase II · A low-input compatible, end-to-end kitted HiChIP workflow for concurrent analyses of transcriptional protein binding and chromatin interactions toward a mechanistic understanding of gene regulation$2.1M
- Federal grantHealth and Human S · Phase II · Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies$999K
- Federal contractHealth and Human S · Arima Genomics INC:1284747 [20-008065]$14K
- Federal contractHealth and Human S · Arima Genomics [20-032501]$19K
- Federal contractHealth and Human S · Reference Quote Number 202007_2_INOUE Arima-hichip Library Preparation Niehs / Inoue Pots [20-008788]$22K
- Federal contractHealth and Human S · Reference Quote # 202006_1_INOUE Niehs Preparation Of 10 Dna Libraries Arima Genomics INC:1284747 Pots [20-008044]$17K
- Federal contractHealth and Human S · Hic Protocol Will Enable The Targeted Identification Of Promoter-enhancer Interactions, And Uncover How Perturbations In Genome Conformation During Aging Impact Gene Regulation. Arima Genomics INC:1284747 [20-007300]$15K
- Federal grantHealth and Human S · Phase II · Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies$999K
- Federal contractHealth and Human S · Arima Genomics INC:1284747 [19-006313]$43K
- Federal grantHealth and Human S · Phase II · Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information$174K
- Federal contractAgriculture · Hi-c Proximity-genome Assembly$13K
- Federal grantHealth and Human S · Phase II · Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing for a wide range of applications$928K
- Federal grantHealth and Human S · Phase II · Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information$1.7M
- Federal grantHealth and Human S · Phase II · Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing?? for a wide range of applications$1.8M
- Federal grantHealth and Human S · Phase I · Maximal resolution and full-length phasing for next-generation MHC-typing$50K
- Federal grantHealth and Human S · Phase I · Optimizing HaploSeq for whole-genome phased haplotypes in biomedical applications$44K
- Federal grantHealth and Human S · Phase I · Optimizing HaploSeq for whole-genome phased haplotypes in biomedical applications$30K
- Federal grantHealth and Human S · Phase I · Maximal resolution and full length phasing for next generation MHC typing$274K
- Federal grantHealth and Human S · Phase I · Maximal resolution and full-length phasing for next-generation MHC-typing$225K
- Federal grantHealth and Human S · Phase I · Non-invasive determination of complete fetal genomes from cfDNA using HaploSeq$291K
- Federal grantHealth and Human S · Phase I · Optimizing HaploSeq for whole-genome phased haplotypes in biomedical applications$380K
- Federal grantHealth and Human S · Phase I · Optimizing HaploSeq for whole-genome phased haplotypes in biomedical applications$19K
- Federal grantHealth and Human S · Phase I · Optimizing HaploSeq for whole-genome phased haplotypes in biomedical applications$350K
Federal awards are summed by year (43 awards); hover a bar for the split. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 42 peers
Line = medianBiotech · Instrument
- Federal grants#2 · top 5%
- Granted patents#10 · top 24%
- Linked publications#6 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 4 granted of 40- PendingMethods And Compositions For Preparing Nucleic Acids That Preserve Spatial-proximal Contiguity InformationUSPTOApplication 19427833
- PendingMethods And Compositions For Identifying Structural VariantsUSPTOApplication 19436931
- GrantedMethods For Detecting The Presence Or Absence Of A Chromosome Rearrangement In A Formalin-fixed Paraffin Embedded (ffpe) Sample With No Detectable Genomic Variant Associated With CancerUSPTOUS 12,534,490
Show all 40 patent records
- Methods And Compositions For Preparing Nucleic Acids That Preserve Spatial-proximal Contiguity InformationMay 7, 2026 · Application 19427833Pending
- Methods And Compositions For Identifying Structural VariantsMay 7, 2026 · Application 19436931Pending
- Methods For Detecting The Presence Or Absence Of A Chromosome Rearrangement In A Formalin-fixed Paraffin Embedded (ffpe) Sample With No Detectable Genomic Variant Associated With CancerJan 27, 2026 · US 12,534,490Granted
- Oncogenic Structural VariantsJun 19, 2025 · Application 18844312Pending
- Methods Of Selecting And Treating Cancer Subjects That Are Candidates For Treatment Using Inhibitors Of A PD-1 PathwayJun 19, 2025 · Application 18844261Pending
- Methods And Compositions For Identifying Structural VariantsJun 5, 2025 · Application 18844316Pending
- Methods Of Selecting And Treating Cancer Subjects That Are Candidates For Treatment Using Inhibitors Of ParpDec 26, 2024 · Application 18825852Pending
- Accurate Molecular Deconvolution Of Mixture SamplesOct 24, 2024 · Application 18436769Pending
- Preserving Spatial-proximal Contiguity And Molecular Contiguity In Nucleic Acid TemplatesAug 1, 2024 · Application 18528553Pending
- Accurate Molecular Deconvolution Of Mixture SamplesJun 25, 2024 · US 12,018,314Granted
- Preserving Spatial-proximal Contiguity And Molecular Contiguity In Nucleic Acid TemplatesJan 16, 2024 · US 11,873,481Granted
- Methods And Compositions For Enhanced Genome Coverage And Preservation Of Spatial Proximal ContiguityJun 30, 2022 · Application 17610414Pending
- Methods And Compositions For Preparing Nucleic Acids That Preserve Spatial-proximal Contiguity InformationJun 28, 2022 · US 11,370,810Granted
- Nucleic Acid ProbesApplication PCTUS2024011120Pending
- Methods And Compositions For Preparing Extracellular Vesicle Nucleic Acids That Preserve Spatial-proximity Information And Applications ThereofApplication 63514335Pending
- Nucleic Acid ProbesApplication PCTUS2023026458Pending
- Methods For Preparation And Analysis Of Proximity-ligated Nucleic Acids From Single CellsApplication PCTUS2023069104Pending
- Methods And Compositions For Preparing Extracellular Vesicle Nucleic Acids That Preserve Spatial-proximity Information And Applications ThereofApplication 63509519Pending
- Methods And Compositions For Preparing Extracellular Vesicle Nucleic Acids That Preserve Spatial-proximity Information And Applications ThereofApplication 19495389Pending
- Methods And Compositions For Identifying Structural VariantsApplication PCTUS2023063807Pending
- Methods Of Selecting And Treating Cancer Subjects That Are Candidates For Treatment Using Inhibitors Of A PD-1 PathwayApplication PCTUS2023014602Pending
- Oncogenic Structural VariantsApplication PCTUS2023063793Pending
- Methods Of Selecting And Treating Cancer Subjects That Are Candidates For Treatment Using Inhibitors Of ParpApplication PCTUS2023063806Pending
- Methods Of Selecting And Treating Cancer Subjects Having A Genetic Structural Variant Associated With PtprdApplication PCTUS2023014608Pending
- Methods And Compositions For Comprehensive Genomic ProfilingApplication 63440886Pending
- Nucleic Acid ProbesApplication 63438512Pending
- Methods And Compositions For Identifying Structural VariantsApplication 63418416Pending
- Nucleic Acid ProbesApplication 63402043Pending
- Oncogenic Structural VariantsApplication 63400865Pending
- Oncogenic Structural VariantsApplication 63400872Pending
- Oncogenic Structural VariantsApplication 63400862Pending
- Methods And Compositions For Identifying Structural VariantsApplication 63400869Pending
- Methods And Compositions For Identifying Structural VariantsApplication 63400878Pending
- Methods Of Selecting And Treating Cancer Subjects Having A Genetic Structural Variant Associated With PtprdApplication 63400873Pending
- Methods And Compositions For Identifying Structural VariantsApplication 63400877Pending
- Oncogenic Structural VariantsApplication 63400861Pending
- Methods Of Selecting And Treating Cancer Subjects That Are Candidates For Treatment Using Inhibitors Of A PD-1 PathwayApplication 63400867Pending
- Nucleic Acid ProbesApplication 63356878Pending
- Methods And Compositions For Identifying Structural VariantsApplication 63322748Pending
- Oncogenic Structural VariantsApplication 63322745Pending
Recent research by its founders
- Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies20261 cites
- Abstract 3259: Detection and functional assessment of extrachromosomal DNA amplifications in FFPE lung tumor specimens using Hi-C sequencing20260 cites
- Abstract 3747: Discovery and functional characterization of enhancer hijacking oncogene rearrangements in NSCLC using Hi-C sequencing of FFPE tumors20260 cites
Related companies, and why
- VASCUMAB LLCSimilar federal contract value in Biotech · $502K in contracts
- Cocrystal Pharma, Inc.Similar federal contract value in Biotech · $498K in contracts
- Mirum PharmaceuticalsSimilar federal contract value in Biotech · $460K in contracts
- APPLIED BIOTECHNOLOGY INSTITUTESimilar federal contract value in Biotech · $450K in contracts
- Nanode Therapeutics, Inc.Similar federal contract value in Biotech · $441K in contracts
- Rejuvenics Technologies LLCSimilar federal contract value in Biotech · $438K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .